Form 4 for BNTX BioNTech SE
Accepted 2026-09-11 17:18:23 ET · period of report 2026-09-10 · accession 0002123975-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-11 17:18 | 2026-09-10 | BNTX | Sahin Ugur | CEO, 10% | S - Sale | $96.31 | -20.5K | 688.2K | -3% | -$1.97M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-10 | S | D | 20,500 | $96.31 | 688,209 | D | — | — |